The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium

GSK Investigational Site, Middelburg

GSK Investigational Site, La Plata

GSK Investigational Site, Kløfta

GSK Investigational Site, Hamar

GSK Investigational Site, Tønsberg

GSK Investigational Site, San Miguel de Tucumán

GSK Investigational Site, Durban

GSK Investigational Site, Stavanger

GSK Investigational Site, Mendoza

GSK Investigational Site, Haugesund

GSK Investigational Site, San Rafael

GSK Investigational Site, Somerset West

GSK Investigational Site, Bellville

GSK Investigational Site, Mowbray

GSK Investigational Site, Gatesville

GSK Investigational Site, Bodø

GSK Investigational Site, Bloemfontein

GSK Investigational Site, Tallinn

GSK Investigational Site, Tallinn

GSK Investigational Site, Berlin

GSK Investigational Site, Berlin

GSK Investigational Site, Berlin

GSK Investigational Site, Tallinn

GSK Investigational Site, Berlin

GSK Investigational Site, Tallinn

GSK Investigational Site, Potsdam

GSK Investigational Site, Potsdam

GSK Investigational Site, Vinnytsia

GSK Investigational Site, Spartanburg

GSK Investigational Site, Greenville

GSK Investigational Site, Hanover

GSK Investigational Site, Hanover

GSK Investigational Site, Dortmund

GSK Investigational Site, Tartu

GSK Investigational Site, Düren

GSK Investigational Site, Mykolayiv

GSK Investigational Site, Witten

GSK Investigational Site, Frankfurt am Main

GSK Investigational Site, Frankfurt am Main

GSK Investigational Site, Kharkiv

GSK Investigational Site, Medford

GSK Investigational Site, Moscow

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Chelyabinsk

GSK Investigational Site, Novosibirsk

GSK Investigational Site, Kemerovo

GSK Investigational Site, Kemerovo

GSK Investigational Site, Irkutsk

GSK Investigational Site, Blagoveshchensk

GSK Investigational Site, Buenos Aires

GSK Investigational Site, Buenos Aires

GSK Investigational Site, Mendoza

GSK Investigational Site, Gyeonggi-do

GSK Investigational Site, Borås

GSK Investigational Site, Gothenburg

GSK Investigational Site, Luleå

GSK Investigational Site, Lund

GSK Investigational Site, Örebro

GSK Investigational Site, Stockholm

GSK Investigational Site, Kiev

GSK Investigational Site, Kyiv

GSK Investigational Site, Kyiv

GSK Investigational Site, Kyiv

GSK Investigational Site, Kyiv